The STMN2 cryptic exon was detected in the motor cortex of half of all ALS patients, with an increasing detection rate observed from pTDP-43 pathology stages 1 to 4 (Fig. 5b). This evidence concerns the gene STMN2 and amyotrophic lateral sclerosis.